Sort Results:

List of Partnerships

  • 1
  • .....
  • 5
 

Argenta and ANTABIO Announce Drug Discovery Collaboration

 

Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration pa...

Partner: ANTABIO
Academic Institute/Non-Profit: Wellcome Trust

Astra Zeneca and Broad Institute to Co-develop Antiviral and Antibacterial Drugs

 

Broad Institute and Astrza Zeneca have entered into a two year collaboration agreement to co-develop antiviral and antibacterial drugs. Screening and target hit to lead chemistry will take place at Broa...

Partner: Astra Zeneca
Academic Institute/Non-Profit: Broad Institute

Astra Zeneca and University of Pennsylvania Partner to Develop Treatments to Manage Obesity

 

Astra Zeneca has entered into a research collaboration agreement with University of Pennsylvania's Institute for Diabetes, Obesity and Metabolism to develop small and or large molecules to manage obesity, ...

Partner: Astra Zeneca
Academic Institute/Non-Profit: University of Pennsylvania's Institute for Diabetes, Obesity and Metabolism

Bayer and UCSF Enter into a 10year Research & Development Partnership

 

Bayer and University of California, San Francisco (UCSF) have signed a 10year master research and development agreement. The agreement provides a broad template for collaboration between the two groups...

Partner: Bayer
Academic Institute/Non-Profit: University of California, San Francisco (UCSF)

Brigham & Woman's Hospital and Sanofi to Partner in Type 1 Diabetes Space

 

Sanofi and Brigham & Woman's Hospital an affiliate of Harvard University have entered into a joint collaboration to develop new drugs based on novel immunomodulatory approach to treat Type 1 Diabetes. ...

Partner: Sanofi
Academic Institute/Non-Profit: Brigham & Woman's Hospital

Cerecor Partners with Johns Hopkins Brain Science Institute to Treat Schizophrenia

 

Cerecor a Baltimore based company has taken an option with Johns Hopkins University to license D-Amino Acid Oxidase inhibitors (DAAO) to treat Schizophrenia. The DAAO inhibitor molecules are currently b...

Partner: Cerecor
Academic Institute/Non-Profit: Johns Hopkins Brain Science Institute ("BSi")

CWHM/OWH Childhood Diarrhea

 

CWHM signed a joint research agreement in 2010 with the Institute for One World Health to discover and develop new drugs to combat diarrhea, which is the second leading cause of death worldwide in children...

Partner: PATH/One World Health
Academic Institute/Non-Profit: CWHM at Saint Louis University

Eisiai Partners with Johns Hopkins Brain Science Institute

 

Eisiai Partners with Johns Hopkins Brain Science Institute ("BSi") an institute which is part of Johns Hopkins University to develop new drugs for neurological diseases. Under this joint collaboration,...

Partner: Eisiai Pharmaceuticals
Academic Institute/Non-Profit: Johns Hopkins Brain Science Institute ("BSi")

Elan and University of Cambridge Establish New Innovation Center

 

University of Cambridge and Elan jointly established Cambridge - Elan Centre for Research Innovation and Drug Discovery. The new center will be based out of Cambridge and will focus primarily in developin...

Partner: Elan
Academic Institute/Non-Profit: University of Cambridge

Evotec and Yale University form Open Innovation Alliance

 

Evotec and Yale intend to leverage first rate science performed at Yale University together with Evotec's drug discovery infrastructure and expertise into highly innovative discovery approaches in diseases...

Partner: Evotec AG
Academic Institute/Non-Profit: Yale University

  • 1
  • .....
  • 5